FIELD: chemistry.
SUBSTANCE: invention relates to a compound of general formula or pharmaceutically acceptable salt thereof, where each of W1 and W2 independently denotes CH; X denotes NR5 or CR6R7, where R5 is hydrogen, C1-8alkyl, and each of R6 and R7 is independently hydrogen; Y denotes -(CR8R9)n-, where each of R8 and R9 independently denotes hydrogen or C1-8alkyl, and n is a number from 1 to 4; or X and Y together form -CR10=CR11-, where each of R10 and R11 independently denotes hydrogen; Z is carboxyl; G denotes O, S or CR12R13, where each of R12 and R13 independently denotes hydrogen; A denotes a 5-member heterocyclic ring selected from a group consisting of thiazole, oxazole and thiophene, in which the heterocyclic ring is optionally substituted with C1-8alkyl; B denotes a C1-8alkylene or C2-8alkenylene chain; each of R1 and R2 independently denotes hydrogen, C1-8alkyl, halogen, C1-8alkyl substituted with halogen, or hydroxyl; each of R3 and R4 independently denotes hydrogen or C1-8alkyl; and m is equal to 0.
EFFECT: compounds of formula (I) act as peroxisome proliferator-activated receptor δ activators.
23 cl, 39 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
ACTIVATING AGENT FOR RECEPTOR ACTIVATED BY PEROXISOME GROWTH-STIMULATING AGENTS | 2009 |
|
RU2501794C2 |
METHOD OF PRODUCING OXAZOLES THROUGH CONDENSATION OF AROMATIC ALDEHYDES WITH ALPHA-KETOXIMES WITH FORMATION OF N-OXIDES AND SUBSEQUENT REACTION WITH ACTIVATED ACID DERIVATIVES | 2005 |
|
RU2402537C2 |
PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR CANCER TREATMENT | 2013 |
|
RU2672916C2 |
APPLICATION OF CHIRAL ARYLKETONES FOR NEUTROPHIL-DEPENDENT INFLAMMATORY DISEASES | 2003 |
|
RU2345759C2 |
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2435763C2 |
SELECTIVE ANTAGONISTS OF ADENOSINE A RECEPTORS | 2007 |
|
RU2467009C2 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2697090C1 |
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
THIENO[2,3-d]PYRIMIDINES AS ANTIMICROBIAL AGENTS | 2018 |
|
RU2803136C2 |
β-D-2ʹ-DEOXY-2ʹ-α-FLUORO-2ʹ-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR TREATMENT OF DISEASES CAUSED BY HCV | 2016 |
|
RU2764767C2 |
Authors
Dates
2011-12-10—Published
2007-04-18—Filed